June 25, 2020
Cancelled conference data trickles out. Digital respiratory-health company Propeller Health recently shared new study data that were accepted for presentation at the now cancelled Society of Behavioral Medicine 2020 Annual Meeting.
The first of the three abstracts described a sample of 617 adults with asthma or COPD, in which older patients engaged with Propeller's app for longer periods of time...
June 24, 2020
FDA begins sharing patient's cancer drug experiences. The FDA's Oncology Center of Excellence has kicked off the first step of new pilot program that will increase the availability of patient-reported outcome data from cancer clinical trials. Project Patient Voice, as it's called, will start with making the data from a single trial accessible online while the agency solicits public feedback, but...
June 9, 2020
Apple COVID screener now updates the CDC. A COVID-19 screening tool first released by Apple in late March can now report users' symptoms, location, health background and other health characteristics to the CDC. The goal is to help the public health agency aggregate more incidence and case data, which can be used to better inform the public about the disease and its risk factors.
These data are...
June 2, 2020
Change Healthcare acquisitions target pharma customers. Nashville, Tennessee-based health IT company Change Healthcare has announced its second major digital pharmacy acquisition in as many months.
Yesterday came news of its $208 million purchase of PDX, a decades-old integrated retail, specialty and outpatient pharmacy software maker. In early May, Change had picked up eRx Network, the maker of...
May 4, 2020
Following numerous reports of underperforming COVID-19 antibody tests, the FDA has raised the bar for these products in a revision to its emergency testing policy.
As of today, commercial manufacturers that notify the agency of their intent to submit a test for Emergency Use Authorization are required to do so within 10 business days from the date of notification. Further, the FDA has recommended...
April 27, 2020
Thanks, but we've got this. The U.K. has decided not to use Apple and Google’s much-anticipated Bluetooth contact tracing tool as originally planned, according to the BBC. Apple and Google’s model pitches a decentralized system for tracing, while the NHSX – which works on the UK’s digital health efforts – is proposing a centralized system.
NHS officials told the BBC that the centralized system...
April 16, 2020
Attacking misinformation head on. Big tech's war against online misinformation is raging hotter than ever with COVID-19. The latest update: Facebook will begin directly contacting users who liked, reacted or commented on "harmful misinformation" about the virus that was later removed by the social network. Facebook wrote this morning that the messages are set to deploy within the coming weeks,...
April 8, 2020
Easy access to (temporarily) free counseling. Consumer telehealth and mail-order prescription services Hims and Hers are dipping into the mental health wellness space. The brands kicked off new anonymized group therapy and guided meditation offerings yesterday, with the therapy sessions led by a licensed mental health practitioner.
The group sessions are currently being offered free of charge in...
April 6, 2020
From me to you. Employee-wellness company Wellable has acquired assets from fellow digital-wellness product-maker MeYou Health, the companies announced. While the terms of the deal were not disclosed, it does transfer ownership of MeYou's Daily Challenge product to Wellable. This program encourages healthy eating, physical activity, stress management and other behaviors through daily email and...
March 12, 2020
Together in perfect harmony. Dexcom and Welldoc have kicked off a new collaboration that will provide Dexcom G6 continuous glucose monitor users with data-analysis insights from Welldoc's digital diabetes management product, BlueStar. These insights include information on how lifestyle factors such as activity, nutrition, sleep and medication adherence are affecting a user's glucose levels.